Thus, rapid muscular glucose clearance, improved insulin sensitivity, and anti-inflammatory signaling likely converge to produce the acute metabolic benefits observed—particularly pronounced in obesity. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.